Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cash Flow from Investing Activities

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Investing Activities ₹-12,712 Cr₹-540 Cr₹-168 Cr₹-2,415 Cr₹-197 Cr

What is the latest Cash Flow from Investing Activities ratio of TORRENT PHARMACEUTICALS ?

The latest Cash Flow from Investing Activities ratio of TORRENT PHARMACEUTICALS is ₹-12,712 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Investing Activities
Mar2026₹-12,712 Cr
Mar2025₹-540 Cr
Mar2024₹-168 Cr
Mar2023₹-2,415 Cr
Mar2022₹-197 Cr

How is Cash Flow from Investing Activities of TORRENT PHARMACEUTICALS Trending?

Years Cash Flow from Investing Activities % Change
Mar2026 ₹-12,712 Cr
Negative
Mar2025 ₹-540 Cr
Negative
Mar2024 ₹-168 Cr
Negative
Mar2023 ₹-2,415 Cr
Negative
Mar2022 ₹-197 Cr -

Compare Cash Flow from Investing Activities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹189,249.0 Cr 1.3% 2% 36.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics
MANKIND PHARMA ₹94,050.4 Cr -1.9% -5.8% -12.9% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

1.3%

2%

36.5%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses